| May 11, 2008 |
| Driving Directions Useful Links Resources For Workers New Jersey Fun Facts Florida Fun Facts Chartie Artificial Disc Injury Lawyers Blog Duragesic Fentanyl Pain Patch Overdose Lawyers Blog Vinyl Chloride Angiosarcoma Liver & Bile Duct Cancer Lawyers Blog Workers Comp & Injury Lawyers Blog Site Map Disclaimer Contact Us Home
|
Gadolinium Related Injury Have you or someone you love been suffering from a Gadolinium related injury or have been diagnosed with Nephrogenic Systemic Fibrosis (NSF) or Nephrogenic Fibrosing Dermotherapy (NSD)? Trust Bagolie Friedman Injury Lawyers to fight for your rights and obtain the justice you deserve. We offer aggressive representation and free consultations. Gadolinium is a contrast agent that helps distinguish between normal and abnormal tissue in the body when used with magnetic resonance imaging (MRI) and/or CT scans. Gadolinium was approved for use in 1988 and has been used in millions of studies since. It is the preferred contrast agent for people with chronic kidney disease. The use of iodine-containing contrast agents is still a common cause of hospital-acquired acute renal failure and is associated with increased mortality & morbidity. On the other hand, gadolinium-based agents, like Omniscan Contrast Dye, have been reported to be safe, well tolerated, and have shown almost no nephrotoxicity in recommended doses. Nephrogenic systemic fibrosis (NSF), described in 2000, is an emerging systemic disorder characterized by widespread tissue fibrosis. NFS was not known to the medical community before March 1997 and some medical authors suggest that the sudden occurrence of the disease in the last 8 years makes it likely that a new agent or technique of examination causes it. Currently, there is no effective treatment available for NSF. Based on recent research, NSF occurs only in patients with advanced or in end stage kidney disease and is strongly related to the use of gadolinium dyes for MRI scans. At this time, there are no known cases of NSF in patients with normal kidney function. NSF / NFD Symptoms
Rapid and full progression of the disease can be fatal. If you experience any of the symptoms of NSF/NFD after and MRI or MRA, you should seek immediate medical attention, and get tested for the disease, even if it has been months since you had the test. Symptoms can appear in a few days after testing, but may not appear for up to 18 months. Many doctors are not aware of or do not believe in the existence of NSF/NFD.
Progression of NSF/NFD NSF/NFD begins as a skin condition. In most people the legs, are affected first, then the feet, arms and hands. In some NSF/NFD patients the trunk of the body is also affected. It rarely affects the face. Skin symptoms start with a thickening of the skin and often red or dark patches will appear. You may experience burning, itching, and/or sharp pains in the affected areas. Eventually the skin develops a wood feel and a texture much like that of an orange peel. Mobility is lost due to tightening and contracture around the joints. It can
become impossible to bend and extend your joints, locking your legs, arms,
hands, and/or feet in place. Many NSF / NFD become so immobilized that they
can no longer perform routine tasks, and can become dependent on wheelchairs
or completely bedridden. NSF / NFD can scar your internal organs so badly that they cannot function. Free Case Review For MRI Contrast Gadolinium Lawsuits We are personal injury and workers' compensation trial lawyers. Contact us now
for a free, confidential and no risk consultation if you have questions about
any type of accident, injury, disability, workers' compensation or disease claim.
Whatever legal problem you have, our personal injury attorneys want to help. |
9/11, WTC Respiratory Lawsuits
15 Passenger Van Rollover
Airbag Failure
Asbestos / Mesothelioma
Auto Accidents
Brake Shift Failure
Cataract Implant Litigation
Charite / Artificial Spinal Disc
Crestor Litigation
Defective Car Seats
Defective Child Safety Seats
Defective Medical Devices
Defective Seat Belts
Defense Base Act Claims
Duragesic Pain Patch Litigation
Environmental Litigation, Chemical Exposure & Toxic Torts
Eye Infection Contact Lens Solution Recall Lawsuit.
Failure to Diagnose or Detect Cancer
Fetal Injury
Firefighters & Paramedic Hearing Loss Litigation
Fosamax Jawbone Lawsuit
Fuel Fed Fire Injury
Gadolinium MRI
Job Related Cancers
Nursing Home Abuse, Neglect and Exploitation
Nursing Home Abuse, Neglect and Exploitation
Nursing Home Abuse - Causes of Abuse and Neglect
Nursing Home Abuse - Signs of Elder Abuse
Nursing Home Abuse - Tips on Choosing a Nursing Home
Nursing Home Abuse - Tips To Help Prevent Abuse or Neglect
Ortho Evra Patch
Lariam Litigation
Lead Paint Poisoning
Medical Malpractice
Municipal Court / Traffic Tickets / DWI
Personal Injury
Product Liability
Railroad / F.E.L.A.
Roof Crush
Silicosis Litigation
Social Security Law
Spinal Cord Injury
Sudden Acceleration
Toxic Mold
Traumatic Brain Injury
Truck & Tractor Trailer Accidents
Unpaid Overtime & Wage and Hour Claims
Vinyl Chloride Litigation
Vinyl Chloride - Bile Duct Cancer
Vinyl Chloride - Liver Cancer
Vioxx / Bextra Litigation
Welding Rod Litigation
White Finger Syndrome
Workers' Compensation |
| © 2007 - Bagolie Friedman, LLC & MegaHunter
Inc. Lawyer Websites - Attorney Websites - Law Firm Websites - Legal Websites Designed by MegaHunter, Inc. Personal Injury Attorneys serving clients in the State of New Jersey. All Rights Reserved. |
Disclaimer: The New Jersey personal injury, wrongful death, worker's compensation, medical malpractice, nursing home abuse, product liability, environmental litigation, social security law, railroad / FELA, firefighter hearing loss, Asbestos / Mesothelioma, Lead Paint Poisoning and/or other legal information offered herein by Bagolie Friedman, LLC - Jersey City and Clifton New Jersey and Hollywood Florida Personal Injury Attorneys is not formal legal advice nor the formation of an attorney client relationship. Our law firm is licensed to practice law in New Jersey, New York and Florida. Nationwide and international coverage through associated counsel. |